Skip to main content
. 2018 Aug 29;11:5261–5268. doi: 10.2147/OTT.S166614

Table 2.

Comparison of median values of ALRI, AST and lymphocytes as a function of toxicity

Number of patients ALRI median value (range) p-values AST median value (range) p-values Lymphocyte median value (range) p-values
Nausea 0.623 0.970 0.733
 G0 153 14.9 (1.3–172.3) 21 (9–193) 1.55 (0.43–10.40)
 G1+G2 124 13.2 (3.2–141.0) 21 (8–100) 1.64 (0.58–10.51)
 G3+G4 7 15.0 (9.3–28.6) 24 (14–28) 1.57 (0.98–2.07)
Vomiting 0.852 0.929 0.687
 G0 217 14.0 (2.1–172.3) 21 (9–193) 1.63 (0.43–5.85)
 G1+G2 60 13.8 (1.4–82.6) 20 (8–100) 1.50 (0.87–10.51)
 G3+G4 7 15.0 (9.2–29.7) 24 (16–35) 1.60 (0.82–2.07)
Diarrhea 0.032 0.194 0.540
 G0 150 14.9 (3.0–172.3) 22 (9–193) 1.57 (0.43–10.51)
 G1+G2 117 13.9 (1.3–141.0) 21 (10–88) 1.57 (0.61–10.40)
 G3+G4 17 11.4 (4.3–33.3) 20 (8–43) 1.93 (0.72–3.75)
Stomatitis 0.230 0.073 0.468
 G0 220 14.0 (1.3–172.3) 20 (8–193) 1.55 (0.43–10.51)
 G1+G2 57 13.8 (4.8–102.3) 23 (11–96) 1.64 (0.77–4.75)
 G3+G4 7 21.0 (12.6–31.0) 30 (17–83) 1.57 (1.25–2.68)
Fatigue 0.010 0.0004 0.220
 G0 159 13.2 (2.1–169.8) 20 (8–117) 1.54 (0.43–5.85)
 G1+G2 106 14.4 (1.3–141.0) 22 (9–142) 1.64 (0.56–10.51)
 G3+G4 19 20.1 (5.1–172.3) 28 (11–193) 1.46 (0.86–2.44)
Anemia 0.221 0.187 0.857
 G0 224 13.8 (1.3–172.3) 21 (8–193) 1.60 (0.43–10.51)
 G1+G2 54 17.1 (3.5–102.3) 23 (10–96) 1.53 (0.72–3.75)
 G3+G4 6 11.4 (4.2–55.4) 16 (12–51) 1.63 (0.92–2.87)
Neutropenia 0.791 0.683 0.182
 G0 101 14.8 (3.0–172.3) 20 (9–193) 1.51 (0.43–3.50)
 G1+G2 58 12.5 (3.5–70.5) 20 (10–117) 1.67 (0.58–3.75)
 G3+G4 124 14.7 (1.3–102.3) 22 (8–100) 1.57 (0.72–10.51)
Thrombocytopenia 0.595 0.367 0.691
 G0 219 14.1 (1.3–172.3) 21 (8–193) 1.60 (0.43–10.51)
 G1+G2 59 13.2 (6.3–102.3) 23 (12–88) 1.60 (0.86–3.98)
 G3+G4 6 19.3 (6.3–33.3) 24 (17–33) 1.47 (0.72–3.15)
Febrile neutropenia 0.515 0.820 0.202
 G0 278 14.1 (1.3–172.3) 21 (8–193) 1.57 (0.43–10.51)
 G1+G2 2 10.3 (3.5–17.0) 20 (10–30) 2.32 (1.76–2.89)
 G3+G4 4 11.5 (8.7–17.2) 23 (18–28) 1.90 (1.57–2.36)
Hemorrhage 0.863 0.713 0.596
 G0 249 13.9 (1.3–172.3) 21 (8–193) 1.57 (0.43–10.51)
 G1+G2 35 15.6 (4.3–74.7) 22 (9–142) 1.68 (0.97–3.75)
 G3+G4 0
Hypertension 0.096 0.429 0.077
 G0 226 14.7 (1.3–172.3) 21 (8–193) 1.57 (0.43–10.40)
 G1+G2 51 11.2 (2.0–82.6) 20 (10–100) 1.69 (0.77–10.51)
 G3+G4 7 17.1 (6.4–102.3) 25 (16–88) 1.46 (0.86–2.97)
Thrombosis 0.379 0.335 0.361
 G0 232 14.1 (1.3–172.3) 21 (8–193) 1.57 (0.43–10.51)
 G1+G2 19 14.6 (4.8–82.6) 21 (12–100) 1.31 (0.56–2.55)
 G3+G4 33 11.9 (3.0–50.0) 20 (9–73) 1.73 (0.72–3.50)
Proteinuria 0.001 0.005 0.514
 G0 221 13.2 (1.4–169.8) 20 (8–117) 1.60 (0.43–10.51)
 G1+G2 63 16.9 (4.2–172.3) 25 (11–193) 1.60 (0.61–3.50)
 G3+G4 0
Neurologic system 0.028 0.168 0.044
 G0 183 15.0 (1.3–172.3) 22 (8–193) 1.58 (0.43–10.40)
 G1+G2 83 13.9 (3.2–102.3) 20 (10–88) 1.55 (0.58–10.51)
 G3+G4 18 9.8 (3.5–50.0) 18 (10.83) 1.88 (1.17–4.75)

Abbreviations: ALRI, aspartate aminotransferase-lymphocyte ratio index; AST, aspartate aminotransferase.